Recent research focusing on Tirzepatide at a dosage of 30mg is shedding new light on its potential effects. Preliminary findings suggest that this higher dosage may boost the drug's ability to control blood sugar, potentially offering improved outcomes for individuals with insulin resistance. Further study is underway to fully evaluate the long-ter